Physician profile
Mary E Araj
NPI 1366025132
$659.68
in general payments reported to CMS, 2019-2025
15 companies · $216 in 2025
The $216 reported for 2025 was more than what 76% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $145 · 2022: $210 · 2023: $65.16 · 2024: $23.99 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $304.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $115.60 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $76.16 | 2021-2022 | |
| Ars Pharmaceuticals Operations, INC. | $75.36 | 2025 | Neffy |
| Sanofi Pasteur INC. | $61.81 | 2022-2025 | |
| Seqirus USA INC | $56.21 | 2021-2023 | Flucelvax Quadrivalent |
| Kowa Pharmaceuticals America, INC. | $54.37 | 2025 | Zoryve |
| Pfizer INC. | $43.21 | 2022-2023 | |
| Collegium Pharmaceutical, INC. | $37.69 | 2025 | Jornay Pm |
| Glaxosmithkline, LLC. | $25.25 | 2021 | |
| Organon LLC | $24.53 | 2025 | Nexplanon |
| Ironshore Pharmaceuticals INC. | $23.99 | 2024 | |
| Cranial Technologies, INC | $18.36 | 2022 | |
| Cepheid | $16.50 | 2022 | |
| Sobi, INC | $16.45 | 2022 | |
| Phadia US INC. | $14.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Araj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.